Published by Alexander Bueso on 1st October 2021
(Sharecast News) - The oral treatment developed by America´s Merck and Ridgeback Biotherapeutics halves the risk of hospitalisation or death among those infected with Covid-19.
URL: http://www.digitallook.com/dl/news/story/32163369/...